Hong et al. demonstrated that PD-L1 tumor proportion score (TPS) was significantly elevated in samples obtained from specific metastatic sites, including adrenal gland, liver and lymph node metastases, in comparison with primary lesions of NSCLC patients [92]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.